Evidence map›Paper›PMID 26184659›Full record

ArticleBMC public health2015

Pilot to evaluate the feasibility of measuring seasonal influenza vaccine effectiveness using surveillance platforms in Central-America, 2012.

Nathalie El Omeiri, Eduardo Azziz-Baumgartner, Wilfrido Clará, Guiselle Guzmán-Saborío, Miguel Elas, Homer Mejía, Ida Berenice Molina, Yadira De Molto, Sara Mirza, Marc-Alain Widdowson and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Nathalie El OmeiriTraining Programs in Epidemiology and Public Health Interventions Network (TEPHINET)/The Taskforce for Global Health, Inc., ᅟ, ᅟ. elomeirin@paho.org.
Eduardo Azziz-BaumgartnerUS Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. eha9@cdc.gov.
Wilfrido ClaráUS Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. xcz0@cdc.gov.
Guiselle Guzmán-SaboríoCosta-Rican Social Security Fund (Caja Costarricense de Seguro Social), San José, Costa-Rica. guiselle23@gmail.com.
Miguel ElasMinistry of Health, San Salvador, El Salvador. migelas@yahoo.com.mx.
Homer MejíaMinistry of Health, ᅟTegucigalpa, Honduras. homams2003@yahoo.com.
Ida Berenice MolinaMinistry of Health, ᅟTegucigalpa, Honduras. paihonduras@yahoo.com.
Yadira De MoltoMinistry of Health, Panama City, Panama. yimolto@gmail.com.
Sara MirzaUS Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. zjk4@cdc.gov.
Marc-Alain WiddowsonUS Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. zux5@cdc.gov.
Alba María Ropero-ÁlvarezComprehensive Family Immunization Project, Pan American Health Organization, Washington D.C., USA. roperoal@paho.org.
Centers for Disease Control and Prevention · USUniversidad Metropolitana de Honduras · HNCosta Rican Department of Social Security · CRMinistry of Health · SVTraining Programs in Epidemiology and Public Health Interventions Network · USWorld Health Organization Regional Office for the Americas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince 2004, the uptake of seasonal influenza vaccines in Latin America and the Caribbean has markedly increased. However, vaccine effectiveness (VE) is not routinely measured in the region. We assessed the feasibility of using routine surveillance data collected by sentinel hospitals to estimate influenza VE during 2012 against laboratory-confirmed influenza hospitalizations in Costa-Rica, El Salvador, Honduras and Panama. We explored the completeness of variables needed for VE estimation.

methodsWe conducted the pilot case-control study at 23 severe acute respiratory infections (SARI) surveillance hospitals. Participant inclusion criteria included children 6 months-11 years and adults ≥60 years targeted for vaccination and hospitalized for SARI during January-December 2012. We abstracted information needed to estimate target group specific VE (i.e., date of illness onset and specimen collection, preexisting medical conditions, 2012 and 2011 vaccination status and date, and pneumococcal vaccination status for children and adults) from SARI case-reports and for children ≤9 years, inquired about the number of annual vaccine doses given. A case was defined as an influenza virus positive by RT-PCR in a person with SARI, while controls were RT-PCR negative. We recruited 3 controls per case from the same age group and month of onset of symptoms.

resultsWe identified 1,186 SARI case-patients (342 influenza cases; 849 influenza-negative controls), of which 994 (84 %) had all the information on key variables sought. In 893 (75 %) SARI case-patients, the vaccination status field was missing in the SARI case-report forms and had to be completed using national vaccination registers (36 %), vaccination cards (30 %), or other sources (34 %). After applying exclusion criteria for VE analyses, 541 (46 %) SARI case-patients with variables necessary for the group-specific VE analyses were selected (87 cases, 236 controls among children; 64 cases, 154 controls among older adults) and were insufficient to provide precise regional estimates (39 % for children and 25 % for adults of minimum sample size needed).

conclusionsSentinel surveillance networks in middle income countries, such as some Latin American and Caribbean countries, could provide a simple and timely platform to estimate regional influenza VE annually provided SARI forms collect all necessary information.

Indexed as

Sentinel SurveillanceAgedCase-Control StudiesCentral AmericaChildChild, PreschoolFemaleHumansInfantInfluenza, HumanInfluenza VaccinesLaboratories, HospitalMaleMiddle AgedPilot ProjectsPolymerase Chain ReactionInfluenza Vaccines

Identifiers

PMID26184659
PMCPMC4504410
OpenAlexW1708279629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.